PharmaTher Holdings Ltd.
PHRRF
$0.06
$0.002.83%
OTC PK
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.31% | -37.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.31% | -37.67% | |||
| Operating Income | 38.31% | 37.67% | |||
| Income Before Tax | 44.41% | -10.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 44.41% | -10.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.41% | -10.15% | |||
| EBIT | 38.31% | 37.67% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 42.86% | -6.06% | |||
| Normalized Basic EPS | 35.29% | 37.04% | |||
| EPS Diluted | 42.86% | -6.06% | |||
| Normalized Diluted EPS | 35.29% | 37.04% | |||
| Average Basic Shares Outstanding | 0.11% | 2.71% | |||
| Average Diluted Shares Outstanding | 0.11% | 2.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||